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aA-crystallin is a molecular chaperone and an antiapoptotic protein. This study investigated the mechanism of inhibition of
apoptosis by human aA-crystallin and determined if the chaperone activity of aA-crystallin is required for the antiapoptotic
function. aA-crystallin inhibited chemical-induced apoptosis in Chinese hamster ovary (CHO) cells and HeLa cells by inhibiting
activation of caspase-3 and -9. In CHO cells, it inhibited apoptosis induced by the overexpression of human proapoptotic
proteins, Bim and Bax. aA-crystallin inhibited doxorubicin-mediated activation of human procaspase-3 in CHO cells and it
activated the PI3K/Aktcell survival pathway by promoting the phosphorylationof PDK1, Akt and phosphatase tensinhomologue
in HeLa cells. The phosphoinositide 3 kinase (PI3K) activity was increased by aA-crystallin overexpression but the protein
content was unaltered. Downregulation of PI3K by the expression of a dominant-negative mutant or inhibition by LY294002
abrogated the ability of aA-crystallin to phosphorylate Akt. These antiapoptotic functions of aA-crystallin were enhanced in a
mutant protein (R21A) that shows increased chaperone activity than the wild-type (Wt) protein. Interestingly, a mutant protein
(R49A) that shows decreased chaperone activity was far weaker than the Wt protein in its antiapoptotic functions. Together, our
study results show that aA-crystallin inhibits apoptosis by enhancing PI3K activity and inactivating phosphatase tensin
homologue and that the antiapoptotic function is directly related to its chaperone activity.
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a-Crystallin isa majorstructural protein of the lens; it accounts
fornearly40%ofthetotalproteininthelensandisrequiredfor
maintenance of lens transparency.
1 The lens grows through-
out age, though at a very slow rate. The proteins in the lens
have negligible turnover and therefore their levels remain
more or less constant during aging. a-Crystallin consists of
two similar subunits, aA- and aB-crystallin, that exist in the
lens as heteroaggregates in a 3:1 ratio with an average
molecular mass of B800kDa. Human aA- and aB-crystallin
share nearly 60% sequence homology.
2 Although aA-crystal-
lin is expressed mainly in the lens and shows low levels
of expression in the retina, aB-crystallin is expressed at
high levels in the lens and in other tissues, such as skeletal
and cardiac muscle, kidney and brain.
3
a-Crystallin belongs to the small heat shock protein (sHSP)
superfamily, featured by a conserved crystallin domain
ﬂanked by an N-terminal and a short C-terminal domain.
4
sHSPs, including a-crystallin, are antiapoptotic proteins that
provide protection against a wide range of cellular stresses.
It has been reported that cells overexpressing aA- or
aB-crystallin are more resistant to thermal,
5 osmotic
6 and
oxidative stress.
7 In addition, recent studies have shown
that a-crystallin prevents apoptosis induced by a variety of
agents, including staurosporine,
8,9 tumor necrosis factor-a,
10
UVA light,
8 hydrogen peroxide
11 and etoposide.
9
The robust effects of a-crystallin against these apoptosis
inducerspromptedmanyresearcherstoinvestigatemolecular
mechanisms by which a-crystallin functions as an antiapop-
totic protein. a-Crystallin has been shown to bind the pro-
apoptotic molecules p53, Bax and Bcl-X(S), and therefore
could prevent their translocation to mitochondria during
apoptosis.
9,12 It has been shown that aB-crystallin can sup-
press autocatalytic maturation of procaspase-3
13,14 and
inhibit cytochrome c release during apoptosis.
15 Whether
aA-crystallin shows these properties is not yet known. During
ﬁber cell differentiation in the lens, a-crystallin suppresses
caspase activity, resulting in the retention of lens ﬁber cell
integrity following degradation of mitochondria and other
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16 This ﬁnding suggests that aA-crystallin might
possess antiapoptotic functions similar to aB-crystallin. UVA-
inducedapoptosisinlensepithelialcellsisinhibitedbyaA-and
aB-crystallins through regulation of PKC-a, RAF/MEK/ERK
and Akt signaling pathways,
17 suggesting additional mechan-
isms of apoptosis inhibition. Phosphorylation of a-crystallin
appears to be important for its antiapoptotic function, as
mimicking phosphorylation of aB-crystallin at serine-59
appears to be sufﬁcient to protect cardiac myocytes from
apoptosis.
18 Whether this property applies for aA-crystallin is
not known.
In addition to being antiapoptotic proteins, both aA- and
aB-crystallins are molecular chaperones; they prevent
aggregation of structurally perturbed proteins.
19,20 It has
been reported that, under heat and other stress conditions,
proteins retain their native secondary structure in the
presence of a-crystallin.
21 A decrease in the chaperone
function of a-crystallin in the aging lens
22 may be one reason
for the onset of age-related cataracts in humans.
Although glycation, a posttranslational modiﬁcation of
proteins by sugars and ascorbate, reduces the chaperone
function of a-crystallin,
23 modiﬁcation of a-crystallin by a
similar process initiated by methylglyoxal (MGO) improves its
chaperone function.
24,25 MGO is a metabolic product derived
from glycolytic intermediates and is present ubiquitously in
humans and in relatively large amounts in the human lens.
26
Reaction of MGO with aA-crystallin produces argpyrimidine
and hydroimidazolone adducts on arginine residues in tissue
proteins, including proteins of the lens.
27,28 We previously
identiﬁed argpyrimidine on R21, R49 and R103 in MGO-
modiﬁed aA-crystallin.
24 Later, we used site-directed muta-
genesisinwhichspeciﬁcarginineresidueswerereplacedwith
alanines and showed that the R21A and R103A mutations
made aA-crystallin a better chaperone, whereas the R49A
mutation made it a weaker chaperone.
29 The double mutant
R21A/R49A was a better chaperone compared with the
unmodiﬁed protein, which implied that R21A mutation over-
rode the negative effect of R49A mutation. These studies
showed that chemical modiﬁcation by MGO may be beneﬁcial
to the chaperone function of aA-crystallin in the lens.
TheR116CandR49CmutationsinhumanaA-crystallinand
R120G and P20S mutations in aB-crystallin, which are
associated with autosomal dominant cataracts in humans,
cause weaker chaperone function along with considerably
lower antiapoptotic functions relative to the wild-type (Wt)
protein.
7,30–32 Despite these advances in our understanding
of a-crystallin’s chaperone and antiapoptotic functions, it is
still not clear whether the two are directly linked. In this study,
we show by several criteria that these functions are intimately
coupled.
Results
Overexpression of human aA-crystallin. We generated
stable cell lines in Chinese hamster ovary (CHO) cells that
overexpressed Wt, R21A or R49A. Clones expressing
human aA-crystallin were analyzed by western blot analysis
using an anti-aA-crystallin antibody (Figure 1a). Puriﬁed
human aA-crystallin of varied concentrations was used to
quantify the expression of human aA-crystallin. Positive clones
expressing comparable amounts of human aA-crystallin,
B2.5ng human aA-crystallin per mg of total protein, were
used. Wt, R21A or R49A were also overexpressed in HeLa
cells by transient transfections (Figure 1b). Our data suggest
that the two cell types expressed similar levels of each
aA-crystallin variant.
R21A mutant protein is a better chaperone in CHO
cells. To determine if overexpressed aA-crystallin shows
chaperone function in CHO cells and if R21A and R49A
mutant show their expected changes in the chaperone
function, we used a glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) aggregation assay. We ﬁrst determined
the optimal temperature and time for complete aggregation of
GAPDH and found that incubation at 551C for 3h resulted in
Figure 1 Overexpression of wild-type (Wt) and mutant aA-crystallins and demonstration of in situ chaperone function. Human Wt, R21A or R49A aA-crystallin in
pCDNA3.1( ) were stably overexpressed in (a) Chinese hamster ovary (CHO) cells and (b) transiently transfected in HeLa cells. aA-Crystallin was detected using anti-aA-
crystallin polyclonal antibody. glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the loading control. (c) Western blot to show that R21A is a better
chaperonethanR49AinCHOcells.Celllysatesofcontrol(Untreated)andthoseincubatedat551Cfor3h(Treated)wereseparatedintosoluble(S)andinsoluble(P)fractions
by centrifugation. GAPDH was detected using an anti-GAPDH monoclonal antibody. GAPDH from rabbit muscle (Sigma) was used as the positive control
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Cell Death and Diseasecomplete aggregation of the pure protein. On the basis of this
result, we incubated cell lysates at 551C for 3h and then
fractioned the lysate into soluble and insoluble fractions
followed by western blotting for GAPDH. We found that in all
cell lysates not subjected to heat treatment, GAPDH was
entirely present in the supernatant fraction (Figure 1c).
However, in heat-treated cell lysates GAPDH was found in
the pellet fraction as well. In the lysate of cells with empty
vector (EV), GAPDH was present entirely in the pellet
fraction and in the lysate of cells with Wt protein, it was
present both in the soluble and insoluble fractions, suggest-
ing Wt protein inhibited aggregation of GAPDH. In the
lysate of cells expressing R21A protein, GAPDH was mostly
present in the supernatant fraction, but it was entirely present
in the pellet fraction in the lysate from cells expressing R49A
protein. These data imply that the overexpressed R21A
mutant protein is a better chaperone and R49A is a weak
chaperone relative to Wt protein in CHO cells.
R21A mutant protein is a better antiapoptotic protein.
We have previously shown that the R21A mutation in human
aA-crystallin increases its chaperone function, whereas
the R49A mutation decreases this function.
29 To determine
whether these changes in chaperone function translate
into a gain or loss of antiapoptotic function, we measured
apoptosis in CHO cell lines incubated with apoptosis-
inducing chemicals, staurosporine or etoposide. In dimethyl
sulfoxide (DMSO)-treated cells, no apoptosis was observed
(data not shown). In EV-transfected cells, B52% cells were
apoptotic on staurosporine treatment. This percentage
increased to B60% in the case of R49A mutant protein-
overexpressing cells. Apoptosis was inhibited by R21A
mutant protein overexpression, and the number of
apoptotic cells was 38%, which was 14% lower than
EV-transfected cells (Figure 2a). Similar results were
observed when apoptosis was induced by 10mM etoposide.
Although cells overexpressing R21A showed nearly 33%
reduction in apoptotic cells, cells overexpressing R49A
showed a 22% increase in apoptotic cells when compared
with EV-transfected cells (Figure 2b). Similar results were
obtained in transiently transfected HeLa cells; R21A was
better and R49A was worse than Wt in preventing apoptosis
induced by either staurosporine (Figure 2c) or etoposide
(Figure 2d). These results indicate that R21A has enhanced
and R49A has reduced antiapoptotic activity, relative to Wt
protein, and that the gain or loss of antiapoptotic function
coincides with the chaperone function of aA-crystallin.
Bax translocation to mitochondria is better inhibited by
R21A. Bax is activated and translocated from the cytosol
into mitochondria during apoptosis. Because it has been
shown that aA-crystallin directly interacts with Bax,
9 we
reasoned that such an interaction could affect translocation
of Bax into mitochondria during apoptosis and that the R21A
mutation may affect this function. To test this hypothesis, we
transiently overexpressed green ﬂuorescent protein
(GFP)-human Bax in CHO cells (stably transfected with
aA-crystallin). Expression of GFP-Bax was conﬁrmed by
western blot analysis (Figure 3a). Cells were fractionated into
cytosolic and membrane fractions. Mitochondria were found
Figure2 R21Aprovidesbetterprotectionagainstapoptosis.ApoptosiswasinducedinaA-crystallinoverexpressingChinesehamsterovary(CHO)cellsandHeLacellsby
either 100nM staurosporine or 10mM etoposide. CHO cells were grown to 100% conﬂuency and then treated with 100nM staurosporine (a)o r1 0mM etoposide (b) in 0.01%
dimethyl sulfoxide (DMSO) for 36h. Similarly HeLa cells were treated with either 100nM staurosporine (c)o r1 0mM etoposide (d) for 24h. Cells were treated with Hoechst
stain to estimate the percentages of apoptotic cells. Bars that do not share a common superscript are statistically signiﬁcant at Po0.0001. In each case, n¼3
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Cell Death and Diseaseto be enriched in the membrane fraction. In cells
overexpressing Wt, Bax was seen in both the cytosolic and
membrane fractions (Figure 3b). By contrast, in R21A-
overexpressing cells, Bax was mainly present in the
cytosolic fraction. Remarkably, in R49A-overexpressing
cells, most of Bax was present in the membrane fraction.
GFP-Bax expression induced apoptosis in CHO cells;
nearly 90% of the cells were apoptotic in GFP-Bax (no
aA-crystallin) cells. This percentage was reduced by about
50% in GFP-Bax/aA-crystallin (Wt) cells and further reduced
by 35% in GFP-Bax/aA-crystallin (R21A) cells. In contrast,
apoptosis increased and reached 90% in GFP-Bax/aA-
crystallin (R49A) cells (Figure 3c). Taken together, these
resultssuggestthatR21AisbetterandR49AisworsethanWt
in preventing Bax translocation to mitochondria and inhibiting
Bax-mediated apoptosis.
R21A provides better protection against Bim-induced
apoptosis. Bim is a BH3-only member of the Bcl2 family
that functions as a death signal sensor.
33 We tested whether
R21A mutant protein is able to prevent Bim-induced
apoptosis better than the Wt protein by transient trans-
fection of human Bim into CHO cells. Western blot analysis
for Bim showed similar levels of expression in all cell lines
(Figure 3d). Similar to Bax overexpression, Bim overexpre-
ssion caused apoptosis in CHO cells. We observed nearly
90% of Bim (no aA-crystallin) cells to be apoptotic; however,
apoptosis decreased to 58 and 43% in Bim/aA-crystallin (Wt)
and Bim/aA-crystallin (R21A) cells, respectively (Figure 3e).
In contrast, nearly 90% of the Bim/aA-crystallin (R49A)
cells were apoptotic. Thus, R21A mutant protein was better
than Wt protein against Bim-induced apoptosis, and this
protection ability was compromised in R49A mutant protein.
R21A offers better protection against cytochrome c
release from mitochondria. Exposure of cells to high
temperatures causes activation of Bax and subsequent
release of cytochrome c from mitochondria.
34 We investi-
gated whether aA-crystallin could inhibit or prevent such
an effect and whether R21A mutant protein performs that
function better than Wt protein. CHO cells were incubated at
431C for 1h, followed by incubation at 371C for another hour.
Figure 3 R21Aprevents Baxtranslocation, Bim-inducedapoptosisand cytochromec releasein Chinesehamsterovary(CHO)cells. (a)Green ﬂuorescent protein (GFP)-
Bax was transiently transfected in cell lines overexpressing Wt, R21A or R49A. Untransfected cells (UT) and cells transfected with the empty vector (EV) were used as
controls.Totalproteinwasextractedfromthecelllysatesand50mgproteinwasseparatedbySDS-PAGE.GFP-Baxwasdetectedbywesternblotusingananti-Baxantibody.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as the loading control. (b) At 15h after transfection with GFP-Bax, cells were subjected to subcellular
fractionation. Approximately 50mg of the cytosolic (C) and membrane (M) fractions were separated by SDS-PAGE. Western blot analysis was performed using an anti-Bax
antibody. GAPDH and manganese superoxide dismutase (MnSOD) served as marker proteins for the cytosolic and membrane fractions, respectively. (c) The percentage of
apoptotic cells was determined by Hoechst staining. (d) Bim was transiently transfected using SuperFect transfection reagent in cell lines to induce apoptosis. Bim was
detected by western blotting using an anti-Bim polyclonal antibody. (e) The percentage of apoptotic cells was determined by staining the cells with Hoechst stain. (f) Stable
cellslines overexpressing Wt, R21A,R49A proteins or empty vector(EV)were incubatedat 431C for 1h, followedbyincubationat 371C for 1h. Cell lysateswere fractionated
into cytosolic (C) and membrane (M) fractions and western blot was performed as mentioned above. Cytochrome c was detected using anti-cytochrome c monoclonal
antibody. Cytosolic and membrane proteins were detected as described above. In (c) and (e) results are presented as the mean±S.D. of n¼3. Bars that do not share a
common superscript are statistically signiﬁcant at Po0.0001
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Cell Death and DiseaseCells were fractionated into cytosolic and membrane
(contains mitochondria) fractions as described above.
Western blotting for cytochrome c in the two fractions
showed that, in R21A mutant protein-overexpressing cells,
cytochrome c was mostly present in the membrane fraction
(Figure 3f), whereas it was mostly present in the cytosolic
fraction in R49A mutant protein-overexpressing cells. Cyto-
chrome c was observed in the cytosolic fraction of cells
transfected with EV, as expected. Cells expressing Wt
protein showed nearly equal quantities of cytochrome c in
the two fractions. These data further strengthen our notion
that R21A mutant protein is a better antiapoptotic agent and
that R49A mutant protein is a weaker antiapoptotic relative
to Wt.
Caspases are less active in R21A mutant protein-
overexpressing cells. Previous studies have shown that
translocation of Bax from the cytosol to mitochondria induces
the release of cytochrome c from mitochondria and thereby
leads to activation of caspases.
35 Because R21A mutant
protein-overexpressing cells sequestered most of Bax in
the cytosol, we tested whether expression of R21A mutant
protein had an effect on the activity of caspases. Apoptosis in
CHO cell lines was induced by treatment with 100nM
staurosporine in DMSO. Cells treated with DMSO alone
served as a control. We measured caspase-3 and -9
activities in cell lysates using their respective ﬂuorogenic
peptide substrates. In Wt cells, caspase-3 and -9 activities
were nearly 30 and 20% lower, respectively, when compared
with cells transfected with the EV (Figure 4a and b). Cells
expressing R21A mutant protein had further reduced acti-
vities, by 52 and 50%, respectively. In contrast, activities of
both caspases were elevated in cells overexpressing R49A
and were comparable to those observed in cells transfected
with vector alone.
Doxorubicin-induced apoptosis in procaspase-3-
overexpressing cells is signiﬁcantly inhibited by
R21A. aB-crystallin inhibits caspase-8-mediated maturation
of procaspase-3 to active caspase-3.
15 We sought to
determine whether the reduced activity of caspase-3
in CHO cell lines (above) is due to aA-crystallin’s ability to
inhibit maturation of procaspase-3, similar to aB-crystallin.
To accomplish this goal, we overexpressed human
procaspase-3 in CHO cell lines and in untransfected CHO
cells, which also allowed us to investigate whether R21A
mutant protein is a better inhibitor of procaspase-3 maturation,
mirroring its other antiapoptotic properties. Western blotting
conﬁrmed overexpression of procaspase-3 in all cell lines
except in untransfected cells; procasapse-3 overexpression
did not result in its autocatalytic maturation (data not shown).
When cells were treated with 20mM doxorubicin for 12h, a
clear increase in cleaved caspase-3 was observed. Caspase-
3 activation was inhibited by R21A mutant protein and to a
Figure 4 R21A prevents activation of caspases. Caspase activities were measured in cells treated with 100nM staurosporine. (a) For caspase-3 activity measurement,
cell lysates were incubated with 50mM DEVD-AFC for 2h at 371C. (b) To determine caspase-9 activity, we used 50mM LEHD-AFC. Samples were read at 400/505nm
excitation/emissionwavelengths.(c)Chinesehamsterovary(CHO)cellsweretransfectedwithhumanprocaspase-3usingSuperFecttransfectionreagentfor48hfollowedby
treatment with 20mM doxorubicin to induce apoptosis. Cell lysates (50mg of protein) were subjected to SDS-PAGE followed by western blotting. (d) Cell lysates were
incubated with 50mM DEVD-AFC for 2h at 371C to determine caspase-3 activity. Samples were read at 400/505nm excitation/emission wavelengths. In each treatment,
n¼3. Bars that do not share a common superscript are statistically signiﬁcant at Po0.0001
Antiapoptotic function of aA-crystallin
N Pasupuleti et al
5
Cell Death and Diseaselesser extent by Wt protein; however, R49A mutant protein
was unable to inhibit caspase-3 activation (Figure 4c). We
then evaluated caspase-3 activity in cells; procaspase-3
overexpression alone did not cause an increase in caspase-
3 activity, but doxorubicin treatment resulted in massive
induction of the enzyme (Figure 4d). Although R21A mutant
protein overexpression signiﬁcantly reduced caspase-3
activity, R49A overexpression was ineffective at reducing the
activity. Wt protein inhibited caspase-3 activity, although this
effect was lower than that of R21A mutant protein. These
results suggest that aA-crystallin inhibits maturation of
procaspase-3 and further conﬁrm that R21A mutant protein
is better than Wt protein, and that R49A mutant form is a
relatively poor inhibitor of procaspase-3 activation.
Enhanced antiapoptotic function of R21A mutant protein
is due to its higher ability to activate PI3K. Akt is
phosphorylated by phosphoinositide 3 kinase (PI3K).
Hsp27, a related heat shock protein, has been shown to
inhibit apoptosis by activating Akt through PI3K.
36 Our
studies on the role of aA-crystallin PI3K signaling pathway
initially used CHO cells. However, we realized that many of
the commercial antibodies to signaling proteins of the PI3K
pathway did not work in CHO cells and therefore we used
HeLa cells in our subsequent experiments. To determine if
aA-crystallin’s ability to inhibit apoptosis was due to its effect
on PI3K, we measured the PI3K activity in HeLa cells
overexpressing Wt and mutant proteins. We found that cells
overexpressing R21A had the higher PI3K activity (B25%
higher) than cells overexpressing Wt protein (Figure 5a).
Cells overexpressing R49A had activity comparable to cells
transfected with the EV. These data suggest that higher PI3K
activity in R21A cells is responsible for its better antiapoptotic
function.
Figure 5 Phosphoinositide 3 kinase (PI3K)-mediated cell survival is enhanced by R21A. (a) PI3K activity was measured by a competitive ELISA in HeLa cells after
transienttransfection(24h)and100nMstaurosporinetreatment(16h).(b)PI3Kexpressionwasdetectedbywesternblotting(50mgofprotein)usingananti-p110apolyclonal
antibody. (c) Cells were treated with 20mM LY294002 for 2h and then treated with 100nM staurosporine (STS). (d) Cell lysates (50mg protein) were subjected to western
blotting to detect pAkt using an anti-pAktantibody andtotal Akt was detectedusing anti-Akt antibody.(e) Cell lines were infectedwith adenovirus containing an EV or a vector
containingdominant-negativePI3K,followedbytreatmentwith100nMSTStoinduceapoptosis.Ineachtreatment,n¼3.Barsthatdonotshareacommonsuperscriptwithin
groups are statistically signiﬁcant at Po0.0001. EV, empty vector, PI3KDN, dominant-negative PI3K
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Cell Death and DiseaseWe then determined if the increased PI3K activity in R21A
cells was due to higher expression of the protein by western
blotting using an antibody to p110a, the catalytic subunit of
PI3K. We found no difference in PI3K protein level in cells
overexpressing Wt or the mutant proteins (Figure 5b). Thus, it
appears that R21A activates PI3K better than the Wt protein
and this ability is lost in R49A.
To conﬁrm whether PI3K is involved in aA-crystallin-
mediated inhibition of apoptosis, we incubated cells with a
PI3Kinhibitor,LY294002.Cellswereincubatedwithorwithout
20mM LY294002 for 2h followed by treatment or nontreat-
ment with 100nM staurosporine. LY294002 treatment alone
increasedapoptosis in untransfected CHO cells; theseeffects
were further enhanced in staurosporine-treated cells
(Figure 5c). In CHO cell lines, treatment with LY294002
completely abolished the antiapoptotic function of Wt protein.
Interestingly, even in R21A cells, the apoptotic rate was
similar to that of the Wt cells. R49A showed responses similar
to those of the Wt and R21A cells. These results suggest that
PI3K activity is required for the antiapoptotic function of
aA-crystallin.
To further conﬁrm the involvement of PI3K, we transduced
our cell lines with dominant-negative PI3K adenovirus or
empty adenovirus to block the activity of PI3K speciﬁcally.
Cells were then treated with staurosporine to induce
apoptosis. The dominant-negative vector has been shown to
inhibit PI3K robustly.
37 We conﬁrmed this effect by measuring
Akt phosphorylation at serine 473 using western blot analysis.
It was completely blocked by expression of the dominant-
negative mutant (Figure 5d), but was unaffected in cells
transduced with EV. Expression of the dominant-negative
mutant alone caused apoptosis (Figure 5e); this effect was
exaggerated by staurosporine treatment. In all cell lines,
expression of the dominant-negative mutant resulted in a
failure to protect against staurosporine-induced apoptosis;
however, transduction of the empty adenovirus vector did not
change the gain or loss of antiapoptotic function in R21A and
R49A. These results suggest that aA-crystallin inhibits
apoptosis through activation of PI3K.
Phosphorylation of Akt, PDK1 and PTEN is elevated by
R21A. The above results suggested that aA-crystallin
inhibits the intrinsic pathway of apoptosis through activation
of the PI3K-mediated signaling pathway. It is well established
that PI3K-mediated activation Akt promotes cell survival.
38 It
has been shown that human aA-crystallin activates the Akt
survival pathway to counteract UVA-induced apoptosis.
17
Therefore, we investigated the downstream signaling of the
PI3K pathway.
Phosphatidylinositol(3,4,5)-triphosphate (PI(3,4,5)P3) pro-
duced from PI3K activity recruits Akt to the plasma mem-
brane. At the plasma membrane, Akt is phosphorylated at
Thr308andSer473byPDK1andPDK2,respectively.
34,39We
analyzedAktphosphorylationinCHOcelllinesaftertreatment
with100nMstaurosporinefor3h.RobustAktphosphorylation
(at Ser473) was observed in R21A mutant protein-over-
expressing cells (data not shown), but this response was
muted in Wt protein-overexpressing cells and was completely
absent in both R49A protein-overexpressing cells and in cells
transfected with the EV. Experiments on HeLa cells allowed
us to determine if phosphorylation occurs on Thr308 as well,
as commercial antibodies to Thr308 phosphorylation did
not work with CHO cells. In 100nM staurosporine-treated
HeLa cells, Akt phosphorylation at both Thr308 and Ser473
was elevated in R21A-overexpressing cells than in cells
overexpressing Wt protein, but such phosphorylation was
completely absent in R49A-overexpressing cells and in
EV-transfected cells (Figure 6a).
One of the upstream kinases that activates Akt is PDK1.
36
We investigated if aA-crystallin activates Akt through activa-
tionofPDK1. InHeLacellstreatedwith100nMstaurosporine,
we found PDK1 to be phosphorylated at Ser241 in R21A-
expressing cells (Figure 6b). This response, although seen
with cells overexpressing Wt protein, was less apparent.
However, PDK1 phosphorylation was not seen in either R49A
protein overexpressing cells or in cells transfected with
the EV.
Next we studied the phosphorylation status of phosphatase
tensin homologue (PTEN) in HeLa cells. PTEN is a dual lipid
and protein phosphatase. PTEN dephosphorylates PI(3,4)P
and PI(3,4,5)P acting as an antagonist of PI3K effects. It is
known that phosphorylation of PTEN at the C-terminal tail
suppresses the activity of PTEN.
40 We found increased
phosphorylation of PTEN in R21A-overexpressing cells when
compared with cells overexpressing Wt (Figure 6c). R49A
overexpressing cells and cells with EV did not show PTEN
phosphorylation. Together these results show that the
increased ability of R21A protein to protect cells from
apoptosis is due to reduced PTEN activity, thus further
promoting activation of Akt through PDK1 phosphorylation.
Discussion
The purpose of this study was twofold: (1) to determine if the
antiapoptotic function of aA-crystallin is related to its
chaperone function and (2) to evaluate whether argpyrimi-
dine-modiﬁable arginine residues that enhance or reduce the
chaperone function dictate the antiapoptotic function. We
have previously shown that MGO, a metabolic dicarbonyl
compound, reacts with Hsp27 and makes it a better
antiapoptotic protein.
41 We also showed that MGO reacts
with speciﬁc arginine residues in aA-crystallin and converts
them to argpyrimidine.
24 We have found that such conversion
at R21 makes aA-crystallin a better chaperone and conver-
sion at R49 makes it a poor chaperone. We then showed that
removal of the positive charge by substitution with alanine at
these sites had the same effect on protein function as
argpyrimidine modiﬁcation.
29 The ﬁnding that the chaperone
function could be modulated by point mutations of speciﬁc
arginine residues enabled us to undertake this study. The
principal ﬁndings of this study are that the enhanced
chaperone function of aA-crystallin strictly correlates with
enhanced protection against the intrinsic apoptosis pathway
and that loss of chaperone function has the opposite effect.
The improvement in antiapoptotic function occurred through
(1) increased PI3K activity and enhanced Akt phosphorylation
by PDK1, (2) increased phosphorylation of PTEN, (3)
increased inhibition of Bax translocation to mitochondria and
Bim-mediated apoptosis, (4)decreasedcytochrome crelease
from mitochondria and (5) increased inhibition of caspase-9
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data clearly suggest that the chaperone function is directly
related and possibly essential for the antiapoptotic function of
aA-crystallin.
Bcl2 family proteins control mitochondrial outer membrane
permeabilization (MOMP).
42 Activation of Bax and/or Bak is
required for MOMP; however, mechanisms by which Bax and
Bak become activated are still being studied. The direct
activation model suggests that BH3-only proteins, such as,
Bim and tBid, can bind directly to Bax and Bak and promote
their activation.
43 The indirect activation model suggests that
Bim binds to antiapoptotic Bcl2 proteins and displaces Bax,
which subsequently results in Bax activation.
44,45 According
to the ﬁrst model, interaction with Bim results in structural
perturbation at the N- and C termini of Bax, which then
translocates to mitochondria, oligomerizes on the mitochon-
drial outer membrane and causes MOMP.
46 We showed that
overexpression of R21A is able to inhibit Bax translocation.
This ﬁnding suggests that R21A could interfere with Bim
binding to Bax, or that it might interact directly with structurally
perturbed Bax through its chaperone property, thereby
blocking its translocation and oligomerization on the mito-
chondrial outer membrane. Along these lines, it has been
shown that heat treatment in a cell-free system induces
Figure 6 R21A inducesAkt, PDK1andphosphatasetensinhomologue(PTEN) phosphorylation.HeLa cells overexpressing humanWt, R21A or R49AaA-crystallinwere
treatedwith100nMstaurosporineor0.01%dimethylsulfoxide(DMSO)for12h.Celllysates(100mgofproteineach)weresubjectedtowesternblotanalysis.(a)pAktlevelsat
Thr308 and Ser473 using an anti-pAkt (Thr308) and anti-pAkt (Ser473) polyclonal antibodies, respectively. Total Akt was detected using an anti-Akt polyclonal antibody.
(b) Detection of pPDK1 and total PDK1 using an anti-pPDK1(Ser241) and anti-PDK1 polyclonal antibodies, respectively. (c) Detection of pPTEN (Ser380/Thr382/383) and
total PTEN using an anti-pPTEN polyclonal and an anti-PTEN polyclonal antibody. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as loading control.
(d) A conceptual mechanism by which aA-crystallin inhibits apoptosis by the PI3K/PDK1/Akt pathway: aA-crystallin inhibits apoptosis by the PI3K/PDK1/Akt pathway. aA-
crystallin enhances the PI3K activity and decreases PTEN activity through phosphorylation (dashed line) leading to increased production and retention of
phosphatidylinositol(3,4,5)-triphosphate (PI(3,4,5)P3). This favors recruitment of Akt to the plasma membrane allowing its phosphorylation at Thr308 and Ser473 by PDK1/2.
Activated Akt then detaches from the membrane and inactivates Bax by phosphorylation. Inactive Bax is unable to translocate to mitochondria, which prevents cytochrome c
release into the cytoplasm. The ensuing inhibition of caspase activation leads to inhibition of apoptosis
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47 and aA-crystallin has
been shown to bind thermally destabilized proteins.
48 Thus, it
is possible that aA-crystallin can bind to structurally perturbed
Bax during its activation by Bim.
When we overexpressed BimEL in CHO cells, it induced
spontaneous apoptosis, as expected.
49 The R21A mutant
was effective, unlike R49A mutant, at inhibiting such
apoptosis. This ﬁnding suggests that R21A interacts directly
with and sequesters Bim or that it binds to Bax and prevents
Bim-mediatedactivationofBax.Furtherstudiesareneededto
test these possibilities.
The lower activity of caspase-3 in R21A cells relative to
R49A cells could be because of either a direct interaction of
aA-crystallin with procaspase-3 or indirect effects through
inhibition of Bax translocation to mitochondria. The former
possibility is supported by observations that aB-crystallin and
Hsp27, two proteins related to aA-crystallin, interact directly
with procaspase-3 and inhibit its activation.
15,50 During
apoptosis, caspase-9 activates procaspase-3 through apop-
tosome formation. It is likely that aA-crystallin, similar to
Hsp27, might bind to the propeptide and inhibit the maturation
process. Work is underway to investigate this possibility.
Thereseemsto beanotherlevel, eitherBax-independent or
-dependent, at which aA-crystallin inhibits apoptosis. PI3K
leads to stimulation of PI-dependent kinase through PIP3,
which increases Akt phosphorylation and, subsequently,
activity of Akt.
36 We found that the PI3K activity was elevated
in R21A cells when compared with Wt cells and was
diminished in R49A cells. However, we did not observe any
signiﬁcant difference in the expression level of PI3K. Exactly
how aA-crystallin activates PI3K is uncertain at this time, but
ourdatapointtothepossibilitythatitcoulddosobyenhancing
the phosphorylation of PI3K. Our study data show that when
PI3K is inhibited either by LY294002 or by a dominant-
negative mutation, the antiapoptotic function of aA-crystallin,
including that of the R21A mutant, is completely abolished.
These observations imply that PI3K/Akt pathway activation is
involved in aA-crystallin’s antiapoptotic function.
A previous study showed that aA-crystallin activates Akt by
phosphorylation at Ser473.
51 Our study showed that in
addition to Ser473, aA-crystallin promotes phosphorylation
at Thr308 and that R21A is better than Wt in promotion of
phosphorylation at these two sites. Our study also showed
that aA-crystallin-mediated Thr308 phosphorylation is due to
an increase in phosphorylation of PDK1 (at Ser241). The
promotion of Akt phosphorylation by R21A could lead to
inhibition of Bax translocation to mitochondria, as phosphory-
lated Akt has been shown to induce Bax phosphorylation,
which leads to its sequestration and heterodimerization with
the antiapoptotic Bcl2 family members, Mcl-1 and Bcl-XL.
52
We cannot rule out other mechanisms by which Akt
phosphorylation could inhibit apoptosis, such as phosphor-
ylation and inhibition of proapoptotic mediators, such as Bad
and caspase-9.
53,54 On the basis of our results, we propose
that aA-crystallin functions as an antiapoptotic protein by
increasing PI3K activity and decreasing the PTEN activity
(Figure 6d).
Webelievethattheﬁndingsofthisstudysigniﬁcantlyimpact
on our understanding of the role of a-crystallin in diseases. In
the human lens the chaperone function of a-crystallin
decreases during aging and cataract formation.
55 On the
basis of the results in this study, we believe that such a
decrease in the chaperone function could reduce its anti-
apoptotic function as well. Whether aA-crystallin content
decreases in the epithelial cells of cataractous lenses is not
clear, but if it does, it could render lens epithelial cells more
susceptible to apoptosis. In fact, in human and experimental
cataracts, lens epithelial cell apoptosis has been observed.
56
Although such apoptosis is not extensive, it may be sufﬁcient
to cause damage to the lens. Lens epithelial cells synthesize
high amounts of a-crystallin. Whether a-crystallin expression
protects epithelial cells from apoptosis in vivo should be
investigated. Previous work using a-crystallin knockout
animals suggests that lens epithelial cells become genomi-
cally unstable and undergo enhanced apoptosis in the
absence of a-crystallin.
57 A recent study showed that
differentiated ﬁber cells undergo apoptosis in the absence of
a-crystallin in the mouse lens.
16
The antiapoptotic function of a-crystallin may also be
important in other tissues. In the ischemic heart, phosphory-
lated aB-crystallin is translocated to mitochondria where it
stabilizes mitochondrial membrane potential and inhibits
apoptosis.
58 a-Crystallin has been shown to protect cancer
cellsfromapoptosisinglioblastoma
59andretinoblastoma.
60A
recentstudyshowedthataB-crystallinisanoncoproteinthatis
highly expressed in breast carcinomas and its expression
independently predicts survival in this disease.
61 a-Crystallin
appears to be important for the prevention of apoptosis
in vascular cells as well. Our previous study using human
umbilical vein endothelial cells showed that hyper-
glycemia-induced apoptosis can be inhibited by overexpres-
sion of aB-crystallin.
62 In addition, we have previously shown
that apoptosis of retinal capillary pericytes, which is asso-
ciated with a decrease in aB-crystallin content, can be
prevented by the overexpression of aB-crystallin.
63 A recent
report shows that aB-crystallin promotes tumor angiogenesis
by increasing endothelial cell survival during tube morpho-
genesis.
64 Thus, it is apparent that aA- and aB-crystallins
are important in the prevention of apoptosis in many different
tissues.
In summary, we have shown in this study that the
antiapoptotic property of aA-crystallin is directly related to its
chaperone function. The fact that modiﬁcation of R21 to
argpyrimidine by a metabolic dicarbonyl MGO had similar
effects on the chaperone function of aA-crystallin, combined
with the present ﬁnding that the R21A mutant protein is
superior to Wt protein in terms of antiapoptotic functions,
suggests that low cellular concentrations of MGO may help
cells to cope with stress by preventing protein aggregation
and apoptosis.
Materials and Methods
Cloning. Wt aA-crystallin cDNA was excised from pCMS-EGFP plasmid using
NheI and XbaI and inserted into pcDNA 3.1( ) vector. R21A cDNA was generated
byPCRusingforwardprimer50-CTGCAGAATTCATGGACGTGACCTCCAGCAC-30
and reverse primer 50-CCCAAGCTTAGGACGAGGGAGCCGAGGT-30 and the
R21A-pET23d plasmid as template. The PCR product was then inserted into
pcDNA3.1( ) vector between ECORI and HindIII restriction sites. R49A cDNA was
ampliﬁed using the R49A-pET23d plasmid as template by PCR using the above
primers and cloned with the same restriction sites as described for R21A.
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Cell Death and DiseaseCell culture. Chinese hamster ovary cells (Invitrogen, Carlsbad, CA, USA) and
HeLa cells were used for the study. Cells were transfected with either empty
pcDNA3.1( ) vectoror vectorcodingfor Wt, R21A or R49AaA-crystallin.Transient
transfections were performed in HeLa cells using SuperFect transfection reagent.
HeLacellswereculturedinDulbecco’smodiﬁedEagle’smediumsupplementedwith
10% fetal bovine serum. CHO cells were used to establish stable cell lines
expressing aA-crystallin using Lipofectamine, according to the manufacturer’s
instructions(Invitrogen).CellswereculturedinHam’sF12mediasupplementedwith
10% fetal bovine serum. Transfected cells were then selected by treatment with
G418 (400mg/ml). Colonies were isolated and individual colonies were expanded.
Eachcolonywasderivedfromasinglecell.Celllysateswerepreparedfrom1 10
6
cells using mammalian protein extraction reagent (MPER) reagent (Pierce, Thermo
Scientiﬁc, Rockford, IL, USA) according to the manufacturer’s protocol. The
expression of aA-crystallin in cell lines was analyzed by western blot using an aA-
crystallin polyclonal antibody(Assay Designs, AnnArbor, MI, USA). Theexpression
levels of aA-crystallin in CHO cell lines were calculated by comparison with
densitometric values obtained from varied concentrations of puriﬁed human
aA-crystallin. Monoclonal mouse antiGAPDH antibody (Chemicon International,
Temecula,CA,USA)wasusedtodetectGAPDH,whichservedasaloadingcontrol.
GAPDH aggregation assay. Stable cell lines were grown to 100%
conﬂuence in Ham’s F12 media containing 10% fetal bovine serum. Cell lysates
were prepared from 10 10
6 cells using MPER reagent and were incubated at
551C for 3h for proteinaggregation.Solubleandinsoluble fractionswereseparated
as described by Hayes et al.
65 and 10mg protein was separated by SDS-PAGE.
Western blot analysis was performed and GAPDH was detected using antiGAPDH
monoclonal antibody (Chemicon International). Puriﬁed GAPDH from rabbit
muscle (Sigma, St Louis, MO, USA) was used as the positive control.
Transient transfection of CHO cell lines with human GFP-Bax,
BimEL and procaspase-3. GFP-Bax and Bim, both in pcDNA3( ) vector
(Shigemi Matsuyama), were transiently transfected into CHO cell lines (each
7 10
5 cells) using SuperFect transfection reagent (Qiagen, Valencia, CA, USA).
To generate full-length caspase-3-FLAG (FL-caspase-3-FLAG), we ampliﬁed
pQE31 plasmid containing the human caspase-3 cDNA
66 using the forward primer
50-GGATCCGAATTC GCCACCATGTCTGGAATATCC-30 and reverse primer 50-A
TCCTCGAGTGTCGACGCGTGATAAAAATAGAG-30. The DNA was cloned into
the BamHI and SalI sites of the mammalian pCMV-(4B)-FLAG expression vector
(Startagene, La Jolla, CA, USA) generating the C-terminal FLAG epitope-tagged
caspase-3. FL-caspase-3-FLAG clones were conﬁrmed by sequencing and protein
expression using the anti-Flag antibody (Clone M2; Sigma). Procaspase-3 in pCMV
vector (Assay Designs) was transiently transfected as described above. In these
experiments,cellstransfectedwithorwithoutEVservedascontrols.Theexpression
of the proteins in transfected cells was conﬁrmed by western blotting (see below).
Westernblotanalysis. CelllysiswasperformedforBax,Bimbyincubationin
a cell lysis buffer obtained from Cell Signaling (Danvers, MA, USA; catalog no.
9803) as per the manufacturer’s instructions. Cell lysis for procaspase-3 was
performed as previously reported.
50 Cell lysates were passed through a 26-gauge
needle several times in the presence of 1mM phenylmethylsulfonyl ﬂuoride and
5ml/mlproteaseinhibitorcocktail(Sigma;catalog no.P8340).Protein concentration
was determined using the Bio-Rad protein assay kit with bovine serum albumin as
the standard. Samples corresponding to 50–100mg protein were electrophoresed
througha15%SDS-PAGEgelandthentransferredontoanitrocellulosemembrane
for 80min at 100V. Nonspeciﬁc binding was blocked by incubation with 5% non-fat
dry milk in Tris-buffered saline-Tween 20 buffer for 1h at room temperature. The
membrane was then incubated with one of the following primary antibodies:
aA-crystallin (polyclonal; Assay Designs), Bax, caspase-3, pAkt (Ser473), pAkt
(Thr308),Akt,pPDK1(Ser241),PDK1,pPTEN(Ser380/Thr382/383),PTEN,p110a
(all polyclonal; Cell Signaling), BimEL (polyclonal; Calbiochem, San Diego, CA,
USA),cytochromec(monoclonal;AssayDesigns),at a1:1000dilutionovernightat
41C. A monoclonal antibody for GAPDH was added at a 1:10000 dilution and
incubated overnight at 41C. HRP-conjugated goat anti-rabbit or goat anti-mouse
secondary antibody was used at a 1:5000 dilution for 1h at room temperature.
Immunoreactivity was detected using SuperSignal West Pico chemiluminescence
substrate (Pierce).
Cell fractionation. Subcellular fractionation to determine Bax translocation
was performed using the Qproteome Cell Compartment Kit (Qiagen). Mitochondrial
and cytosolicfractions were separated accordingto the manufacturer’sinstructions.
Manganese superoxide dismutase (MnSOD; mitochondrial marker protein) was
detected using an anti-MnSOD polyclonal antibody (Santa Cruz Biotechnology,
Santa Cruz, CA, USA). Cytosolic marker protein GAPDH was detected by anti-
GAPDH antibody.
Induction of apoptosis. Stable cell lines were grown to 100% conﬂuence in
Ham’s F12 media containing 10% fetal bovine serum in the presence of 400mg/ml
G418. Cells were then placed in media containing 0.01% DMSO (control) or DMSO
containing 100nM staurosporine or 10mM etoposide for 24–36h or 20mM
doxorubicin for 12h. After treatment, all samples were collected and analyzed for
apoptosis. The percentage of apoptotic and viable cells was measured by Hoechst
staining. A total of 300 cells were counted. The percentage of apoptotic cells and
viable cells relative to the total number of cells was calculated.
Caspase-3 and -9 activities. Cells were collected and lysed as described
above. Cell lysates were incubated in a black microwell plate for 2h at 371C with
50ml of either 50mM DEVD-AFC in 10% glycerol, 50mM 1,4-piperazinediethane-
sulfonicacid (pH 7.0),1mMEDTA,1mMdithiothreitolto measurecapase-3activity
or 50mM LEHD-AFC in the same buffer to measure caspase-9 activity. Samples
were read at 400/505nm excitation/emission wavelengths using a Spectramax
Gemini XPS spectroﬂuorometer (Molecular Devices, Sunnyvale, CA, USA).
PI3K activity assay. The activity of PI3K was determined using the PI3K
activity ELISA Kit (Echelon Biosciences, Salt Lake City, UT, USA). HeLa cells were
transiently transfected with either EV or vector harboring Wt, R21A and R49A
mutant of human aA-crystallin for 24h. Cells were treated with 100nm
staurosporine for 16h. Cell lysate was used for immunoprecipitation of PI3K
using an anti-PI3K antibody (Upstate Biotechnology, Temecula, CA, USA) and
a competitive ELISA was used to measure PI3K activity following the
manufacturer’s protocol.
Blocking of PI3K activity in CHO cell lines. For inhibition of PI3K
activity, CHO cells were grown to 100% conﬂuence in Ham’s F12 media and
incubatedwith or without 20mM LY294002for 2h. Cells without the inhibitor served
as the control. Following the treatment, cells were incubated with or without 100nM
staurosporine for 36h. Cells were stained with Hoechst stain to measure apoptosis
as described above. To block PI3K activity in cells, we transduced cells with an
adenovirusharboringadominantnegativeformofPI3K(PI3KDN-PI3K).
67CHOcell
lineswereplatedovernightatadensityof1 10
5cellsper2mlinHam’sF12media
in 6- or 12-well plates and were then infected overnight with 2.5 10
10 PFU per ml
with either an empty adenovirus or adenovirus carrying DN-PI3K. The transduction
efﬁciency was previously established to be greater than 95%.
67 Cells were washed
once with PBS, and were then cultured for an additional 24h in 2ml of Ham’s F12
medium containing 100nM staurosporine.
Statistics. Data are expressed as mean±S.D. Statistical signiﬁcance among
groupswas analyzedbyANOVAfollowedby theFisher’sleastsigniﬁcantdifference
test. Po0.05 was considered statistically signiﬁcant.
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